CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

CareRx CorporationTSX: CRRX.TO

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q1 FY2026 accounts payables was -CA$3.91M, compared with CA$793K a year earlier. Trailing-twelve-month accounts payables was -CA$5.6M.

Context

  • Accounts payables amounted to 0.2% of revenue in FY2025, down 0.7 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -CA$3.91M or moves back toward the trailing-twelve-month quarterly average of -CA$1.4M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$3.91M-257.6% QoQ
Last fiscal yearDec 2025
-CA$891K-125.7% YoY
LTMMar 2026
-CA$5.6M-185.0% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-593.2%——
1 year-125.7%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

CAD · from the cash flow

Latest · FY2025
(891K) CAD
Year-over-year change
-125.7%

Accounts Payables vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -185.0% is the 4th highest of 5, against a peer median of +23.0%.
  • Accounts payables amounts to 1.5% of revenue for CRRX.TO, versus a peer median of 1.8%.
CRRX.TO Competitors
Accounts Payables for CRRX.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$6.02M CAD-234.6%—3.8%
CRRX.TOCareRx CorporationLTM Mar 2026CA$5.6M CAD-185.0%—1.5%
DR.TOMedical Facilities CorporationLTM Mar 2026$4.49M USD+349.5%-8.9%1.5%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$925.95K USD+123.4%-35.8%1.7%
PRN.TOProfound Medical Corp.LTM Mar 2026$379.28K USD-77.5%—2.0%
HBP.TOHelix BioPharma Corp.LTM Apr 2026CA$0 CAD———
Peer median (excluding CRRX.TO) —+23.0%-22.4%1.8%

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(22.73M)(34.35M)(5.41M)(4.5M)26.13M
Depreciation & Amortization15.39M20.07M19.98M19.19M18.33M
Deferred Income Tax(1.01M)(1.54M)(4.19M)32K(22.77M)
Stock-Based Compensation2.67M4.57M1.47M3.65M2.72M
Change in Working Capital(3.73M)638K2.12M8.98M(988K)
Accounts Receivables(11.72M)1.51M1.47M3.82M247K
Inventory(2.83M)(2M)648K1.55M(126K)
Accounts Payables15M816K(181K)3.46M(891K)
Other Working Capital(4.17M)307K186K145K(218K)
Other Non-Cash Items16.67M32.96M13.4M10.64M4.12M
Operating Cash Flow7.27M22.33M27.38M37.99M27.54M
Capital Expenditures(7.12M)(13.61M)(8.7M)(8.11M)(5.59M)
Acquisitions (Net)(86.13M)(2.99M)(3.66M)196K39K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities67K(3.57M)(3.93M)(2.53M)0
Investing Cash Flow(93.18M)(16.6M)(12.31M)(7.92M)(8.26M)
Debt Repayment30.35M(5.29M)(39.82M)(21.58M)(4.32M)
Common Stock Issued80.86M1.01M14.68M014K
Common Stock Repurchased00(56K)(801K)(2.24M)
Dividends Paid0000(1.26M)
Other Financing Activities(9.3M)(8.71M)(11.2M)(5.64M)(6.64M)
Financing Cash Flow101.91M(12.99M)(36.4M)(28.02M)(14.44M)
Effect of Forex Changes00000
Net Change in Cash16M(7.25M)(21.34M)2.06M4.84M
Free Cash Flow153K8.72M18.68M29.88M21.95M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.